BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

South Korea

South Korea’s Celltrion Secures EU Approval for Three Biosimilar Products, Expanding Its Portfolio to 11 by 2025

Celltrion gains simultaneous regulatory approval of two monoclonal antibody biosimilars across three treatments – Eydenzelt® (aflibe...

February 19, 2025 | News

VIVOZON’s UNAFRA Inj. Secures MFDS Approval as South Korea’s First First-in-Class Non-Opioid Analgesic

VIVOZON Pharmaceutical announced that its non-opioid analgesic, UNAFRA Inj., was approved on December 12, 2024. (active ingredient: Opiranserin H...

February 19, 2025 | News

DAAN Biotherapeutics and LigaChem Biosciences Forge Exclusive Licensing Deal to Advance ADC Development

DAAN Biotherapeutics, a leading innovative drug development company specializing in T-cell receptor (TCR)- based therapies, has signed an exclusive licensi...

February 14, 2025 | News

LG Chem Begins Prototype Production of 100% Bio-Acrylic Acid in South Korea

LG Chem has launched prototype production of 100% bio-acrylic acid, which has received USDA Certified Biobased Product (BIOPREFERRED®) label. The pr...

February 13, 2025 | News

LG AI Research Partners with Seoul National University to Advance Protein Multistate Prediction AI

LG AI Research signed a joint research agreement at the Global Lounge of LG Science Park in Magok, Gangseo-gu, Seoul, with Prof. Min-Kyung Baek&n...

February 10, 2025 | News

Lunit Partners with SITC to Launch AI-Powered Research Program for Cancer Immunotherapy

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, has entered into a partnership with the Society ...

February 04, 2025 | News

GC Cell Hosts Landmark Symposium in Indonesia to Spotlight Immuncell-LC Cancer Immunotherapy

GC Cell, a leading cell and gene therapy company, announced the successful completion of its first thought leadership symposium in Jakarta, Indonesia....

January 24, 2025 | News

GI Innovation and LaNova Medicines Join Forces for Breakthrough Pancreatic Cancer Combination Therapy

GI Innovation (KQ:358570) announced that it signed a Memorandum of Understanding (MOU) with LaNova Medicines (LaNova) for the development o...

January 23, 2025 | News

Hyundai ADM Bio Showcases Innovative Oral Chemotherapy OTX-M at Biotech Showcase 2025

Hyundai ADM Bio (Co-CEOs Taek-Sung Kim and Kwang-Hee Kim) announced the results of its preclinical study on the oral anti-cancer drug O...

January 23, 2025 | News

Samsung Biologics Eyes Growth in 2025 with New Plant, ADC Services, and Sustainability Investments

Recorded Q4'24 consolidated revenue of KRW 1.26 trillion Recorded FY'24 consolidated revenue of KRW 4.55 trillion Poised for further growth w...

January 23, 2025 | News

GordonMD and South Korea’s Partners Investment Join Forces to Drive Biopharma Innovation

GordonMD Global Investments® LP (“GordonMD”), a US-based investment manager focused exclusively on global public and private biopharma...

January 22, 2025 | News

Nextbiomedical Secures FDA IDE Approval for U.S. Clinical Trial of Nexsphere-F™ in Knee Osteoarthritis

NEXTBIOMEDICAL CO., LTD, a KOSDAQ-listed innovative medical device company in South Korea, proudly announced that it has received Investigational Devi...

January 16, 2025 | News

SN BioScience Secures FDA IND Clearance for SNB-101 Phase 1b/2 Trial, Targeting Extensive Stage Small Cell Lung Cancer

SN BioScience announced that its lead asset SNB-101 has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administra...

January 13, 2025 | News

Sciwind Biosciences Partners with Verdiva Bio in $2.4 Billion Deal to Advance Global Metabolic Disease Therapies

Hangzhou Sciwind Biosciences Co., a pre-commercial biopharmaceutical company focusing on developing innovative therapies to treat metabolic diseases, ...

January 13, 2025 | News

Stay Connected